DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
PICTILISIB
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
PI3-kinase class I inhibitor
PICTILISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
ICY00EMP8P
Molecule Type:
Small molecule
Molecular Formula:
C23H27N7O3S2
Molecular Weight:
513.65
AlogP:
2.15
PSA:
107.55
HBD:
1.0
HBA:
#RotB:
5.0
Source:
UC1010
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UC1010
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTOFISOPAM
2
Small molecule
Investigational
Unknown
Unknown
Irritable Bowel Syndrome
Unknown
DEXTOFISOPAM
×
Maximum Phase:
2
First Approval:
None
UNII:
EZ15I5D6C1
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O4
Molecular Weight:
382.46
AlogP:
4.44
PSA:
61.64
HBD:
0.0
HBA:
#RotB:
6.0
Source:
APILIMOD
2
Small molecule
Investigational
Unknown
Unknown
Common Variable Immunodeficiency; Crohn Disease; Severe Acute Respiratory Syndrome
1-phosphatidylinositol 3-phosphate 5-kinase inhibitor
APILIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
GFW2K84S4L
Molecule Type:
Small molecule
Molecular Formula:
C23H26N6O2
Molecular Weight:
418.5
AlogP:
3.08
PSA:
84.76
HBD:
1.0
HBA:
#RotB:
8.0
Source:
GW468816
2
Small molecule
Investigational
Unknown
Unknown
Tobacco Use Disorder
Glutamate [NMDA] receptor antagonist
GW468816
×
Maximum Phase:
2
First Approval:
None
UNII:
3WGI8FOO62
Molecule Type:
Small molecule
Molecular Formula:
C20H17ClN2O3
Molecular Weight:
368.82
AlogP:
3.8
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PF-4191834
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Osteoarthritis, Knee
Arachidonate 5-lipoxygenase inhibitor
PF-4191834
×
Maximum Phase:
2
First Approval:
None
UNII:
YX55DXP4T1
Molecule Type:
Small molecule
Molecular Formula:
C22H23N3O2S
Molecular Weight:
393.51
AlogP:
3.77
PSA:
70.14
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SQ109
2
Small molecule
Investigational
Unknown
Unknown
Helicobacter Infections; Tuberculosis
Unknown
SQ109
×
Maximum Phase:
2
First Approval:
None
UNII:
9AU7XUV31A
Molecule Type:
Small molecule
Molecular Formula:
C22H38N2
Molecular Weight:
330.56
AlogP:
4.68
PSA:
24.06
HBD:
2.0
HBA:
#RotB:
9.0
Source:
FLUOROFURANYLNORPROGESTERONE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROFURANYLNORPROGESTERONE
×
Maximum Phase:
2
First Approval:
None
UNII:
K56K9G4PPM
Molecule Type:
Small molecule
Molecular Formula:
C25H29FO5
Molecular Weight:
428.5
AlogP:
4.72
PSA:
65.74
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TONABERSAT
2
Small molecule
Investigational
Unknown
Unknown
Migraine with Aura; Migraine without Aura
Unknown
TONABERSAT
×
Maximum Phase:
2
First Approval:
None
UNII:
2XD9773ZMN
Molecule Type:
Small molecule
Molecular Formula:
C20H19ClFNO4
Molecular Weight:
391.83
AlogP:
3.68
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PROPIONIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PROPIONIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
JHU490RVYR
Molecule Type:
Small molecule
Molecular Formula:
C3H6O2
Molecular Weight:
74.08
AlogP:
0.48
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TIPEPIDINE
2
Small molecule
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity; Cough; Depressive Disorder
Unknown
TIPEPIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
2260ZP67IT
Molecule Type:
Small molecule
Molecular Formula:
C15H17NS2
Molecular Weight:
275.44
AlogP:
4.34
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ME-401
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ME-401
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INECALCITOL
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute
Vitamin D receptor agonist
INECALCITOL
×
Maximum Phase:
2
First Approval:
None
UNII:
05FZV98342
Molecule Type:
Small molecule
Molecular Formula:
C26H40O3
Molecular Weight:
400.6
AlogP:
4.76
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
3.0
Source:
AZD5672
2
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Arthritis, Rheumatoid
C-C chemokine receptor type 5 antagonist
AZD5672
×
Maximum Phase:
2
First Approval:
None
UNII:
61XQN688TW
Molecule Type:
Small molecule
Molecular Formula:
C31H43F2N3O5S2
Molecular Weight:
639.83
AlogP:
4.07
PSA:
95.07
HBD:
0.0
HBA:
#RotB:
11.0
Source:
ETHION
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ETHION
×
Maximum Phase:
2
First Approval:
None
UNII:
2TI07NO12Y
Molecule Type:
Small molecule
Molecular Formula:
C9H22O4P2S4
Molecular Weight:
384.49
AlogP:
5.01
PSA:
36.92
HBD:
0.0
HBA:
#RotB:
12.0
Source:
OC000459
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Dermatitis, Atopic; Eosinophilic Esophagitis; Rhinitis, Allergic, Seasonal
G protein-coupled receptor 44 antagonist
OC000459
×
Maximum Phase:
2
First Approval:
None
UNII:
04XB9TB8OL
Molecule Type:
Small molecule
Molecular Formula:
C21H17FN2O2
Molecular Weight:
348.38
AlogP:
4.31
PSA:
55.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GALUNISERTIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Glioma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Carcinoma, Hepatocellular; Glioblastoma; Myelodysplastic Syndromes; Nasopharyngeal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms
TGF-beta receptor type I inhibitor
GALUNISERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
3OKH1W5LZE
Molecule Type:
Small molecule
Molecular Formula:
C22H19N5O
Molecular Weight:
369.43
AlogP:
3.51
PSA:
86.69
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SONEDENOSON
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Foot
Adenosine A2a receptor agonist
SONEDENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
2OT4KAG5JL
Molecule Type:
Small molecule
Molecular Formula:
C18H20ClN5O5
Molecular Weight:
421.84
AlogP:
0.29
PSA:
148.77
HBD:
4.0
HBA:
#RotB:
6.0
Source:
OLEIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Glioma; Multiple Sclerosis; Adenoma
Unknown
OLEIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
2UMI9U37CP
Molecule Type:
Small molecule
Molecular Formula:
C18H34O2
Molecular Weight:
282.47
AlogP:
6.11
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
R-406
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase SYK inhibitor
R-406
×
Maximum Phase:
2
First Approval:
None
UNII:
RC3A285J2G
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN6O5
Molecular Weight:
470.46
AlogP:
3.63
PSA:
128.75
HBD:
3.0
HBA:
#RotB:
7.0
Source:
SODIUM 2,2-DIMETHYLBUTYRATE
2
Small molecule
Investigational
Unknown
Unknown
Anemia, Sickle Cell; beta-Thalassemia
Unknown
SODIUM 2,2-DIMETHYLBUTYRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
XKM99SPB5I
Molecule Type:
Small molecule
Molecular Formula:
C6H11NaO2
Molecular Weight:
138.14
AlogP:
1.51
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
XBD173
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
XBD173
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R-333
2
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Tyrosine-protein kinase JAK3 inhibitor
R-333
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SITAMAQUINE
2
Small molecule
Investigational
Unknown
Unknown
Leishmaniasis
Unknown
SITAMAQUINE
×
Maximum Phase:
2
First Approval:
None
UNII:
5AIJ4TGC6B
Molecule Type:
Small molecule
Molecular Formula:
C21H33N3O
Molecular Weight:
343.52
AlogP:
4.87
PSA:
37.39
HBD:
1.0
HBA:
#RotB:
11.0
Source:
EMRICASAN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Digestive System Diseases; Liver Diseases; Severe Acute Respiratory Syndrome; Hepatitis, Alcoholic; Hepatitis C, Chronic; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease
Caspase inhibitor
EMRICASAN
×
Maximum Phase:
2
First Approval:
None
UNII:
P0GMS9N47Q
Molecule Type:
Small molecule
Molecular Formula:
C26H27F4N3O7
Molecular Weight:
569.51
AlogP:
2.59
PSA:
150.9
HBD:
4.0
HBA:
#RotB:
10.0
Source:
TOLPERISONE
2
Small molecule
Investigational
Unknown
Unknown
Muscle Spasticity; Arthralgia; Myalgia
Unknown
TOLPERISONE
×
Maximum Phase:
2
First Approval:
None
UNII:
F5EOM0LD8E
Molecule Type:
Small molecule
Molecular Formula:
C16H23NO
Molecular Weight:
245.37
AlogP:
3.3
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MPC-5971
2
Small molecule
Investigational
Unknown
Unknown
Kidney Calculi
Unknown
MPC-5971
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C18H20K2MgO21
Molecular Weight:
674.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SAM-760
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SAM-760
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENRASENTAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Endothelin receptor ET-A antagonist
ENRASENTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
QG16H8A6ZH
Molecule Type:
Small molecule
Molecular Formula:
C29H30O8
Molecular Weight:
506.55
AlogP:
4.56
PSA:
103.68
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ETARFOLATIDE
2
Small molecule
Investigational
Unknown
Unknown
Ovarian Neoplasms; Adenocarcinoma of Lung; Breast Neoplasms
Unknown
ETARFOLATIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
40UB1H6Q6T
Molecule Type:
Small molecule
Molecular Formula:
C29H34N10O11S
Molecular Weight:
730.72
AlogP:
-2.86
PSA:
337.88
HBD:
11.0
HBA:
#RotB:
19.0
Source:
DOCOSAPENTAENOIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Substance-Related Disorders
Unknown
DOCOSAPENTAENOIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
NS3OZT14QT
Molecule Type:
Small molecule
Molecular Formula:
C22H34O2
Molecular Weight:
330.51
AlogP:
6.77
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
GALLIUM
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
GALLIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
CH46OC8YV4
Molecule Type:
Small molecule
Molecular Formula:
Ga
Molecular Weight:
69.72
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CARICOTAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
CARICOTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
MC09H30MFS
Molecule Type:
Small molecule
Molecular Formula:
C8H11N3O2
Molecular Weight:
181.19
AlogP:
-0.94
PSA:
89.42
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VOFOPITANT
2
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Sleep Initiation and Maintenance Disorders; Stress Disorders, Post-Traumatic
Neurokinin 1 receptor antagonist
VOFOPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
K08BK043YS
Molecule Type:
Small molecule
Molecular Formula:
C21H23F3N6O
Molecular Weight:
432.45
AlogP:
3.27
PSA:
76.89
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BL-1020
2
Small molecule
Investigational
Unknown
Unknown
Psychotic Disorders; Schizophrenia
Unknown
BL-1020
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H34Cl2N4O2S
Molecular Weight:
525.55
AlogP:
4.23
PSA:
62.04
HBD:
1.0
HBA:
#RotB:
10.0
Source:
1
2
…
99
100
101
102
103
104
105
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA